OverviewSuggest Edit

Abingdon Health is a specialist medical diagnostics company based in London. They work with the world’s best scientists to acquire, develop and distribute state-of-the art diagnostic tools and services. Their mission is to create a global, diversified healthcare business through both selective acquisition and the development of patent protected, clinically relevant diagnostic products.
TypePrivate
Founded2008
HQNorth Yorkshire, GB
Websiteabingdonhealth.com

Latest Updates

Employees (est.) (Oct 2020)74(+11%)
Revenue (FY, 2018)£2.3 M(+64%)
Cybersecurity ratingAMore

Key People/Management at Abingdon Health

Michael Hunter

Michael Hunter

Operations Director
Marsha Leeman

Marsha Leeman

QARA Director
Show more

Abingdon Health Office Locations

Abingdon Health has an office in North Yorkshire
North Yorkshire, GB (HQ)
National Innovation Campus, Sand Hutton York
Show all (1)

Abingdon Health Financials and Metrics

Summary Metrics

Founding Date

2008

Abingdon Health total Funding

$12.9 m

Abingdon Health latest funding size

$4.75 m

Time since last funding

5 years ago

Abingdon Health investors

Abingdon Health's latest funding round in June 2015 was reported to be $4.8 m. In total, Abingdon Health has raised $12.9 m
Show all financial metrics

Abingdon Health Revenue

Abingdon Health's revenue was reported to be £2.27 m in FY, 2018
GBP

Revenue (FY, 2018)

2.3m

Gross profit (FY, 2018)

1.7m

Gross profit margin (FY, 2018), %

74.3%

Net income (FY, 2018)

3.5m

EBITDA (FY, 2018)

(4.5m)

EBIT (FY, 2018)

(4.7m)

Cash (30-Jun-2018)

476.9k
GBPFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2018

Revenue

78.0k782.8k1.9m1.2m1.1m1.4m2.3m

Revenue growth, %

(37%)(5%)

Cost of goods sold

358.4k696.0k328.7k326.0k333.4k583.1k

Gross profit

424.4k1.2m852.1k792.1k1.1m1.7m
GBPFY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2018

Cash

38.2k44.5k46.0k1.2m921.0k1.2m1.7m2.0m476.9k

Accounts Receivable

11.5k98.04.3k112.7k235.2k106.7k147.8k362.2k96.0k

Inventories

125.6k127.8k155.6k134.6k256.1k389.2k

Current Assets

49.7k44.6k50.4k1.9m1.7m2.2m3.0m3.5m1.7m
GBPFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2018

Net Income

33.8k(1.4m)(1.2m)(2.6m)(2.5m)(3.2m)3.5m

Cash From Operating Activities

36.8k(894.0k)(851.3k)(1.3m)(1.8m)(1.7m)(2.6m)

Cash From Financing Activities

(16.5k)3.4m911.3k1.6m2.7m2.8m1.4m

Net Change in Cash

19.6k1.2m(299.8k)240.1k565.4k307.8k(1.6m)
GBPFY, 2009

Financial Leverage

-0.4 x
Show all financial metrics

Abingdon Health Cybersecurity Score

Cybersecurity ratingPremium dataset

A

95/100

SecurityScorecard logo

Abingdon Health Online and Social Media Presence

Embed Graph

Abingdon Health Blogs

Design freeze for AbC-19TM lateral flow test for IgG antibodies to the SARS-COV-2 virus

Abingdon Health is delighted to announce the UK-RTC has reached design freeze for the AbC-19TM lateral flow test for IgG antibodies to the SARS-COV-2 virus (COVID-19). Achievement of this major milestone led by Abingdon Health’s R&D department means the test meets the required performance charac…

Abingdon Health appoint Professor Mike Holmes as a medical advisor

Professor Mike Holmes appointed as a medical advisor to support Abingdon Health’s work on developing SARS-CoV-2 rapid tests. The post Abingdon Health appoint Professor Mike Holmes as a medical advisor appeared first on Abingdon Health.

Abingdon Health appoints Lyn Rees as Non-Executive Director

Abingdon Health appoints Lyn Rees as non-executive director and board member. The post Abingdon Health appoints Lyn Rees as Non-Executive Director appeared first on Abingdon Health.

Abingdon Health announces its latest expansion and additional manufacturing capacity

Investment in state-of-the-art automation cements Abingdon Health’s position as a leading global rapid test manufacturer The post Abingdon Health announces its latest expansion and additional manufacturing capacity appeared first on Abingdon Health.

Professor Lawrence S. Young appointed as a scientific advisor to Abingdon Health

Professor Lawrence S. Young appointed as a scientific advisor to support Abingdon Health's work on developing SARS-CoV-2 rapid tests. The post Professor Lawrence S. Young appointed as a scientific advisor to Abingdon Health appeared first on Abingdon Health.

UK-Rapid Test Consortium (“UK-RTC”) – Progress update

The UK-RTC has made significant progress in developing a COVID-19 lateral flow antibody test that can be used by people in their homes, since its inception 7 weeks ago. In addition, we have also made progress with the regulatory and logistics challenges needed to be overcome to support the Governmen…
Show more

Abingdon Health Frequently Asked Questions

  • When was Abingdon Health founded?

    Abingdon Health was founded in 2008.

  • Who are Abingdon Health key executives?

    Abingdon Health's key executives are Michael Hunter and Marsha Leeman.

  • How many employees does Abingdon Health have?

    Abingdon Health has 74 employees.

  • What is Abingdon Health revenue?

    Latest Abingdon Health annual revenue is £2.3 m.

  • What is Abingdon Health revenue per employee?

    Latest Abingdon Health revenue per employee is £30.7 k.

  • Who are Abingdon Health competitors?

    Competitors of Abingdon Health include CardioDx, Best Doctors and Applied BioCode.

  • Where is Abingdon Health headquarters?

    Abingdon Health headquarters is located at National Innovation Campus, Sand Hutton York, North Yorkshire.

  • Where are Abingdon Health offices?

    Abingdon Health has an office in North Yorkshire.

  • How many offices does Abingdon Health have?

    Abingdon Health has 1 office.